Antigua and Barbuda vs Senegal: Estimated antiretroviral therapy coverage among people living with HIV
Antigua and Barbuda
77.0%
in 2025
Senegal
77.0%
in 2025
Antigua and Barbuda rank
64th
Senegal rank
64th
Estimated antiretroviral therapy coverage among people living with HIV over time
- Antigua and Barbuda
- Senegal
How they compare
Antigua and Barbuda currently reports 77.0% against 77.0% in Senegal, a difference of 0.0%.
The two have swapped places 3 times across 26 shared years of data; in 2000 it was Antigua and Barbuda ahead.
Antigua and Barbuda ranks 64th and Senegal ranks 64th of 143 countries.
Across the 3 decades both report, Antigua and Barbuda averaged higher in 1 and Senegal in 2.
Head to head by decade
| Decade | Antigua and Barbuda | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 15.5% | 5.8% | 9.7% | Antigua and Barbuda |
| 2010s | 43.8% | 43.9% | 0.1% | Senegal |
| 2020s | 66.5% | 74.7% | 8.2% | Senegal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Antigua and Barbuda or Senegal?
- Antigua and Barbuda, at 77.0% against 77.0% in Senegal as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Antigua and Barbuda and Senegal?
- 0.0%, with Antigua and Barbuda ahead.
- How many years of comparable data are there for Antigua and Barbuda and Senegal?
- 26 years are reported by both, from 2000 to 2025.
- How do Antigua and Barbuda and Senegal rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Antigua and Barbuda ranks 64th and Senegal ranks 64th of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.